Author name: womenzbiz.US Editorial Team

Networking in a Virtual World

The large, in-person networking event is actually off-putting these days, redefined by COVID-19, but networking is still an essential tool to build business and a career. Consider that 80% of all open positions aren’t advertised but instead found through personal connections! According to Korn Ferry, 85% of all positions are actually filled via networking.  Pandemic […]

Networking in a Virtual World READ MORE

BrainScope and Aon Secure IP-based Funding Deal

Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its platform. “More than four million

BrainScope and Aon Secure IP-based Funding Deal READ MORE

FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain High Risk Early Breast Cancer

Eli Lilly announced last month that the U.S. Food and Drug Administration (FDA) had approved its Verzenio (abemaciclib) for a specific type of early breast cancer that is at high risk of recurrence after surgery. The drug is limited to patients who test at least 20% for a Ki-67 score on an FDA-approved test. Ki-67 is a marker of cellular

FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain High Risk Early Breast Cancer READ MORE

Shopping Cart
Scroll to Top